Aster Capital Management’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Buy
+558
New +$11.8K ﹤0.01% 754

Other funds holding NVCT

Aster Capital Management's NVCT Position: Q3 2026 in Review

Aster Capital Management opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 558 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #754 among its holdings.

95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Aster Capital Management held 558 shares of Nuvectis Pharma worth $11.8K as of Q3 2026.
  • Nuvectis Pharma was a new Aster Capital Management position in Q3 2026.
  • Nuvectis Pharma made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #754 holding.
  • 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.